| Methotrexate studied in …STUDIED_INderived200 of 728show all (up to 200) |
|---|
| → studied in | NCT04628767Phase 2/Phase 3 · recruiting Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer · 728 trials list this drug (131 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691478Phase 2/Phase 3 · suspended A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma · 728 trials list this drug (131 active) | — | — | Osteosarcoma,Secondary Osteosarcoma,High Grade Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · 728 trials list this drug (131 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Burkitt Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05663866Phase 2 · active not recruiting Premedication to Reduce Amivantamab Associated Infusion Related Reactions · 728 trials list this drug (131 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07560826Phase 2 · recruiting The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645718Phase 2 · recruiting Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015242Phase 2 · recruiting A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma · 728 trials list this drug (131 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003222Phase 3 · active not recruiting Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293562Phase 3 · recruiting A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations · 728 trials list this drug (131 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920737Phase 2 · active not recruiting A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · 728 trials list this drug (131 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05998642Phase 2 · recruiting Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma · 728 trials list this drug (131 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216524Phase 2 · recruiting Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · 728 trials list this drug (131 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387926Phase 1/Phase 2 · recruiting Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) · 728 trials list this drug (131 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964090Phase 2 · active not recruiting Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) · 728 trials list this drug (131 active) | — | — | Central Nervous System Lymphoma,Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609046Phase 1 · active not recruiting Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma · 728 trials list this drug (131 active) | — | — | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751512Phase 3 · recruiting A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN · 728 trials list this drug (131 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06973811Phase 2 · recruiting ZR-MTX for PIOL Phase II Trial · 728 trials list this drug (131 active) | — | — | Primary Intraocular Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150693Phase 3 · recruiting Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114229Phase 2 · active not recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · 728 trials list this drug (131 active) | — | — | Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04546399Phase 2 · recruiting A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203526Phase 1 · active not recruiting Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530565Phase 3 · active not recruiting Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · 728 trials list this drug (131 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05761171Phase 2 · active not recruiting A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247787Phase 1 · recruiting A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy · 728 trials list this drug (131 active) | — | — | Childhood Myelodysplastic Syndrome,Juvenile Myelomonocytic Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036577Phase 1 · completed A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185373Phase 2/Phase 3 · recruiting Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228624Phase 2 · recruiting Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes · 728 trials list this drug (131 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724457Phase 2/Phase 3 · not yet recruiting Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma · 728 trials list this drug (131 active) | — | — | Burkitt Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719105early Phase 1 · recruiting Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma · 728 trials list this drug (131 active) | — | — | Aggressive NK-Cell Leukemia,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227584Phase 2 · recruiting ALL Backbone in AYAs · 728 trials list this drug (131 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764601NA · not yet recruiting R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678229Phase 3 · recruiting BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL · 728 trials list this drug (131 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390319Phase 2 · recruiting Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) · 728 trials list this drug (131 active) | — | — | T Acute Lymphoblastic Leukemia,T-Cell Non-Hodgkin Lymphoma,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05137262Phase 2 · active not recruiting A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder · 728 trials list this drug (131 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143414Phase 2 · active not recruiting Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06960577Phase 3 · recruiting Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) · 728 trials list this drug (131 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177067Phase 1 · recruiting Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400946Phase 3 · completed 05-001: Treatment of Acute Lymphoblastic Leukemia in Children · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981628Phase 2 · active not recruiting Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03488225Phase 2 · terminated Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914625Phase 3 · active not recruiting A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072585Phase 2/Phase 3 · not yet recruiting Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) · 728 trials list this drug (131 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101853Phase 3 · active not recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112916Phase 3 · active not recruiting Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Childhood T Acute Lymphoblastic Leukemia,Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686107Phase 2 · not yet recruiting Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML." · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02416388Phase 2/Phase 3 · recruiting Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR · 728 trials list this drug (131 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020030Phase 3 · active not recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents · 728 trials list this drug (131 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533748Phase 2 · recruiting Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501826Phase 2 · recruiting Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371630Phase 1/Phase 2 · recruiting Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06289673Phase 4 · recruiting Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303792Phase 2 · active not recruiting Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321912Phase 2 · recruiting Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma · 728 trials list this drug (131 active) | — | — | Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689630Phase 3 · recruiting Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02422641Phase 2 · recruiting Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis · 728 trials list this drug (131 active) | — | — | Malignant Breast Neoplasm,Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03703271Phase 3 · recruiting Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia · 728 trials list this drug (131 active) | — | — | Gestational Trophoblastic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571321Phase 1 · recruiting Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393859Phase 3 · completed Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895473Phase 2 · recruiting Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphatic System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553460Phase 1/Phase 2 · active not recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408005Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07643103Phase 2 · not yet recruiting Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636564Phase 2 · not yet recruiting Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747912Phase 2 · recruiting Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544115Phase 2 · active not recruiting Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders · 728 trials list this drug (131 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · 728 trials list this drug (131 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Acute Leukemia of Ambiguous Lineage+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01190930Phase 3 · completed Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05157971Phase 1 · active not recruiting Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02427620Phase 2 · active not recruiting Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Mantle Cell Lymphoma,Blastoid Variant Mantle Cell Lymphoma,Pleomorphic Variant Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02710734Phase 2 · completed Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02877303Phase 2 · recruiting Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263572Phase 2 · recruiting Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03710772Phase 2 · active not recruiting Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · 728 trials list this drug (131 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730542Phase 1 · recruiting Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma · 728 trials list this drug (131 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03808610Phase 1/Phase 2 · terminated Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03286634Phase 2 · active not recruiting ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 · 728 trials list this drug (131 active) | — | — | Childhood Malignant Neoplasm,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997068Phase 2 · recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population · 728 trials list this drug (131 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lip and Oral Cavity Neoplasm,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04043494Phase 3 · recruiting International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872790Phase 1 · active not recruiting Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498465Phase 1 · withdrawn A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206671Phase 3 · active not recruiting Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents · 728 trials list this drug (131 active) | — | — | Mature B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00558519Phase 2 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04898894Phase 1 · active not recruiting Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04960579Phase 1 · active not recruiting P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma · 728 trials list this drug (131 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05519579Phase 2 · recruiting Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07361133Phase 2 · not yet recruiting Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer · 728 trials list this drug (131 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01424982Phase 2 · active not recruiting Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03684980early Phase 1 · active not recruiting LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma · 728 trials list this drug (131 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04547049Phase 3 · active not recruiting A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies · 728 trials list this drug (131 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329325Phase 2 · active not recruiting Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011920Phase 2 · completed Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma · 728 trials list this drug (131 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207123Phase 1/Phase 2 · recruiting A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) · 728 trials list this drug (131 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06918431Phase 2 · recruiting Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Lymphoblastic Lymphoma,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477457Phase 2 · recruiting A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma · 728 trials list this drug (131 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970096Phase 2 · recruiting Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) · 728 trials list this drug (131 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02723994Phase 2 · completed A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965597Phase 2 · completed Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) · 728 trials list this drug (131 active) | — | — | Hematologic Neoplasm with Germline GATA2 Mutation,Hematologic Neoplasm with Germline SAMD9 Mutation,Hematologic Neoplasm with Germline SAMD9L Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475235Phase 1 · recruiting Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL · 728 trials list this drug (131 active) | — | — | Lymphoma,Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410520Phase 2 · recruiting PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL. · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma,Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03913559Phase 2 · terminated Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523976Phase 2 · completed Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842696Phase 1/Phase 2 · active not recruiting Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation · 728 trials list this drug (131 active) | — | — | Acute Leukemia,Myelodysplastic Syndrome,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252870Phase 2 · recruiting Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336024Phase 3 · completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma · 728 trials list this drug (131 active) | — | — | Medulloblastoma,Anaplastic Medulloblastoma,Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121014Phase 2 · active not recruiting Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes · 728 trials list this drug (131 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856478Phase 3 · completed LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy · 728 trials list this drug (131 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466798Phase 1 · withdrawn Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies · 728 trials list this drug (131 active) | — | — | Central Nervous System Neoplasm,Medulloblastoma,Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301138Phase 2 · not yet recruiting BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06085742Phase 2 · recruiting BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer · 728 trials list this drug (131 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611037Phase 2 · completed Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma · 728 trials list this drug (131 active) | — | — | Malignant Mesothelioma,Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06387121Phase 2 · recruiting Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541249Phase 2 · recruiting MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial · 728 trials list this drug (131 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881086Phase 3 · completed Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03589326Phase 3 · active not recruiting A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214626Phase 2 · completed R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06128070Phase 2 · recruiting Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00136435Phase 2 · completed A Study in Adults With Untreated Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760226early Phase 1 · completed Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies · 728 trials list this drug (131 active) | — | — | Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03680092Phase 2 · completed Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579769Phase 2 · terminated Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192889Phase 1/Phase 2 · active not recruiting Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383743Phase 2 · completed Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer · 728 trials list this drug (131 active) | — | — | Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698147Phase 1/Phase 2 · recruiting Selinexor in Combination With MTX+Ritu to Treat R/R CNSL · 728 trials list this drug (131 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860844Phase 2 · terminated Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05583071Phase 2 · recruiting Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL · 728 trials list this drug (131 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562558NA · active not recruiting Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia · 728 trials list this drug (131 active) | — | — | Choriocarcinoma,Gestational Trophoblastic Tumor,Invasive Hydatidiform Mole | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05032183Phase 1/Phase 2 · terminated Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Lymphoblastic Lymphoma,Adult Lymphoblastic Lymphoma,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04440267Phase 2 · recruiting Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06262438Phase 2 · recruiting CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05660473Phase 2 · recruiting Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878254Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354393Phase 2 · completed Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma · 728 trials list this drug (131 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02329080Phase 2 · completed New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement · 728 trials list this drug (131 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03817320Phase 1/Phase 2 · active not recruiting PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00476190Phase 2 · completed ALL Adult Consortium Trial: Adult ALL Trial · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470223Phase 3 · active not recruiting Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma · 728 trials list this drug (131 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420717Phase 2 · terminated Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541665Phase 1 · active not recruiting Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040464Phase 3 · recruiting Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384654Phase 2 · completed A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752163Phase 1/Phase 2 · terminated DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05959720recruiting Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04571697completed A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04737889Phase 2 · recruiting Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03813147Phase 1 · completed Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · 728 trials list this drug (131 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643276Phase 3 · recruiting Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 · 728 trials list this drug (131 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085617completed Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02905110early Phase 1 · completed Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03792256Phase 1 · completed Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) · 728 trials list this drug (131 active) | — | — | Acute Leukemia,Lymphoblastic Lymphoma,Lymphoid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04314219Phase 3 · recruiting Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02828358Phase 2 · completed Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390793Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03495960Phase 2 · completed Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299999Phase 2 · active not recruiting SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer · 728 trials list this drug (131 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01976182Phase 2 · completed Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01228331Phase 2/Phase 3 · completed Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476770Phase 1 · recruiting Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,B-Cell Malignant Neoplasm,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05522582Phase 2 · active not recruiting Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors · 728 trials list this drug (131 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177695Phase 2 · completed S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer · 728 trials list this drug (131 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554561Phase 1/Phase 2 · recruiting A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma · 728 trials list this drug (131 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554626Phase 2 · recruiting Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL · 728 trials list this drug (131 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277924Phase 1/Phase 2 · completed Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas · 728 trials list this drug (131 active) | — | — | Bone Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664910Phase 1/Phase 2 · completed CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies · 728 trials list this drug (131 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557193Phase 3 · completed Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia,Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210750Phase 2 · withdrawn Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) · 728 trials list this drug (131 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05899751unknown Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01979536Phase 2 · completed Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Anaplastic Large Cell Lymphoma, ALK-Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653068Phase 3 · completed Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System · 728 trials list this drug (131 active) | — | — | Childhood Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959241Phase 3 · completed TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) · 728 trials list this drug (131 active) | — | — | Lymphoma,Acute Leukemia,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06336395Phase 2 · recruiting Ma-Spore ALL 2020 Study · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381680Phase 3 · completed Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia · 728 trials list this drug (131 active) | — | — | Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309732Phase 2 · completed GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) · 728 trials list this drug (131 active) | — | — | Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858740Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · 728 trials list this drug (131 active) | — | — | Acute Leukemia of Ambiguous Lineage,Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036868Phase 2 · completed Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer · 728 trials list this drug (131 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01884623Phase 3 · completed Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer · 728 trials list this drug (131 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01527149Phase 2 · completed Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma · 728 trials list this drug (131 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186328Phase 1 · terminated EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) · 728 trials list this drug (131 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663622Phase 2 · completed Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02385110Phase 2 · completed Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis · 728 trials list this drug (131 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03864419Phase 1 · terminated Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda · 728 trials list this drug (131 active) | — | — | Burkitt Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175702not yet recruiting Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916979Phase 1 · completed Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG · 728 trials list this drug (131 active) | — | — | Lymphoma,Lymphoid Leukemia,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574496Phase 2 · completed Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma · 728 trials list this drug (131 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003838Phase 2 · completed Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122081Phase 1 · completed Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies · 728 trials list this drug (131 active) | — | — | Myelodysplastic Syndrome,Adult Acute Lymphoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01951885Phase 3 · completed Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention · 728 trials list this drug (131 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |